Increasing Contingency Management Success in Smoking Cessation

This study has been completed.
Sponsor:
Collaborators:
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:
NCT00273793
First received: January 4, 2006
Last updated: June 14, 2012
Last verified: June 2012

January 4, 2006
June 14, 2012
June 2005
June 2010   (final data collection date for primary outcome measure)
Breath Carbon Monoxide Levels Indicating Smoking Abstinence During the Study, i.e., the Number of Breath Samples With Carbon Monoxide (CO) Levels Less Than 3 Parts Per Million (Ppm) [ Time Frame: daily for breath CO ] [ Designated as safety issue: No ]
Breath Carbon Monoxide levels indicating smoking abstinence during the study, and at follow-up six months after study entry
Complete list of historical versions of study NCT00273793 on ClinicalTrials.gov Archive Site
Average Number Cigarettes Reported Smoked Each Day in the Past Week Measured at Follow-up Six Months After Entry Into the Study [ Time Frame: past week at follow-up six months after study entry ] [ Designated as safety issue: No ]
average number cigarettes reported smoked each day in the past week at follow up six months after study entry
cigarrettes reported smoked
Not Provided
Not Provided
 
Increasing Contingency Management Success in Smoking Cessation
Increasing Contingency Management Success Using Shaping

Incentives can be used to facilitate the acquisition of many healthy behaviors, such as smoking cessation. However, there is much room for improvement in the use of incentives. This study investigates how two aspects of providing incentives influence the effectiveness of using incentives to promote smoking cessation. One aspect is the criterion for providing incentives, e.g., whether to require smoking cessation before providing an incentive or to provide incentives following smoking reductions. The other aspect being investigated is whether it is best to use a fixed incentive amount or an amount that increases with continued cessation success.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Smoking
Behavioral: Contingency Management
incentives are available for reduced smoking on each study visit which occur each weekday.
  • Experimental: 1
    Shaping intervention for hard-to-treat smokers
    Intervention: Behavioral: Contingency Management
  • Active Comparator: 2
    fixed criterion intervention for hard-to-treat smokers
    Intervention: Behavioral: Contingency Management
  • 3
    Non contingent incentives available to hard to treat smokers
    Intervention: Behavioral: Contingency Management
  • Experimental: 4
    Ascending incentives values used in Smokers with Early Success
    Intervention: Behavioral: Contingency Management
  • Active Comparator: 5
    fixed value incentives are used in Smokers with Early Success
    Intervention: Behavioral: Contingency Management
  • 6
    Non contingent incentives are available to Smokers with Early Success
    Intervention: Behavioral: Contingency Management
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
328
November 2010
June 2010   (final data collection date for primary outcome measure)

Inclusion Criteria: Daily Smokers smoking a pack or more of cigarettes a day who are able to report to the study site each work day for about 5 minutes for around 3 months. Subjects must also have a breath CO level indicative of smoking at this level, and most report smoking for at least two years. Subjects must intend on quitting smoking.

-

Exclusion Criteria: Participation in another study by this group within the past year. Inability to give informed consent. Incapable of attendance each workday during the morning hours.

-

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00273793
045-0013-195, R01DA013304
Not Provided
The University of Texas Health Science Center at San Antonio
The University of Texas Health Science Center at San Antonio
  • National Institute on Drug Abuse (NIDA)
  • National Institutes of Health (NIH)
Principal Investigator: Richard J Lamb, Ph.D. The University of Texas Health Science Center at San Antonio
The University of Texas Health Science Center at San Antonio
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP